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Introduction
Human polymorphic nuclear granulocytes such as neutrophils and eosinophils play a critical role in mediating inflammatory responses to microbial and parasitic infection 1 . At the site of infection, granulocytes participate in the inflammatory reaction by phagocytosis, intracellular killing of bacteria, production of inflammatory mediators and release of pre-formed cytotoxic enzymes and proteins. Environmental factors can quickly amplify these granulocyte functions by a mechanism termed "priming" which is independent of protein synthesis [2] [3] [4] . Priming refers to a process by which the response of cells to a subsequent (activating) stimulus is amplified if these cells were previously exposed to a (priming) stimulus. This process is an important regulatory mechanism whereby phagocytes can be controlled while responding to the local conditions of their environment. For example, prior exposure of human eosinophils to either the cytokine granulocyte-macrophage colony-stimulating factor (GM-CSF) or the inflammatory mediator platelet-activating factor (PAF) will greatly enhance the ability of these cells to be activated by subsequent exposure to opsonized particles 5;6 . While many studies have analyzed the effects of granulocyte priming, little is known concerning the molecular mechanisms that lead to this phenomenon. Recent studies have demonstrated the cytokine-mediated activation of various intracellular signaling pathways in human granulocytes, while the use of specific pharmacological inhibitors has implicated some of these events in the regulation of cell effector functions [7] [8] [9] [10] [11] [12] . It is however unclear whether cytokine may also result in changes in granulocyte gene expression that might correlate with this phenomenon. Indeed, cytokine-induced regulation of gene expression in human granulocytes and the functional consequences thereof have not been studied in any detail.
In an attempt to gain further insight into the pathogenesis of inflammatory responses and also to identify potential markers for granulocyte priming, we have utilized the technique of differential-display 13 . This PCR-based technique is allows the identification and cloning of genes that are differentially expressed in cells under pre-determined conditions. The advantage of this technique lies in its ease of operation and the ability to process many samples at one time unlike previous methodologies such as subtractive hybridization. Utilizing a modified differential display technique, Random Arbitrary Primed (RAP)-PCR 14 , we have analyzed the expression of genes either up-or downregulated in human PMNs after treatment with physiological concentrations of GM-CSF. Several known genes were identified in vitro and their regulation by GM-CSF was confirmed by Northern blotting. Furthermore, we demonstrate that one of the genes identified, 5-lipoxygenase activating protein (FLAP), was also up regulated in vivo in peripheral blood leukocytes after allergen challenge. These data confirm that differential-display technology can indeed be utilized to gain further insight into the mechanisms of granulocyte priming and pathogenesis of inflammatory reactions.
Materials and Methods

Isolation of human granulocytes.
Blood was obtained from a healthy donor with no history of allergy or asthma . There was no relevant clinical history (no allergy, no parasitic infection, no indications of other eosinophilic diseases). However, a persistent (>10 years) finding blood of slight leukocytosis (~8x10 9 leukocytes/liter) and 30% eosinophils in the granulocyte fraction was observed. Apart from the elevated amount of eosinophils the remainder of the leukocyte population was within the normal range. Total leukocytes 7.3x10 9 /litre: 2% basophils, 18% eosinophils, 34% neutrophils, 35%
lymphocytes and 11% monocytes. Mononuclear cells were removed by centrifugation over Ficoll-paque (density 1,077/cm 3 ) , 1000xg, 20 min at RT.
The lower cell layer was collected and the remaining erythrocytes were lyzed by incubation in isotonic 115mM ammonium chloride solution (pH 7.4) on ice for 20 min. After centrifugation the granulocytes were incubated in RPMI-1640 (Life Technologies, Paisley, UK) containing 0.5% HSA (wt/vol) for 30 min at 37°C. Cells were washed with PBS and half of the cells were stimulated with GM-CSF (10 -10 M) for 3 hours in RPMI-medium supplemented with 25mM Hepes, 8% fetal calf serum (FCS, Hyclone), 1 mg/ml penicillin and 1 mg/ml streptomycin in a CO 2 incubator (5% CO 2 , 37°C).
RNA isolation.
Total RNA was isolated as follows: 10 8 cells were resuspended in 500 µl sterile PBS and 10 µl of RNAsin (Promega, Madison, WI) was added. The cells were lyzed in 20 ml of GIT solution (6M guanidine thiocyanate, 25mM sodium citrate, 0.5% N'Lauroyl sarcosine, 100mM β-mercaptoethanol). One volume of sodium acetate (2M, pH 4.0) was added and an equal volume of phenol followed by vortexing. Half of the total volume of chloroform/iso-amylalcohol was added to the solution and vortexed. The solution was incubated on ice for 15 min and centrifuged at 4°C for 20 min at 10.000xg. The upper phase was extracted with half volume of chloroform/isoamylalcohol and centrifuged for 2 min. RNA was precipitated with an equal volume of 2-propanol and 200mg of carrier glycogen at -20 °C for overnight. Samples were centrifuged at 81000 rpm for one hour, re-suspended in a small volume and RNA was re-precipitated with ethanol. Poly A + mRNA was extracted by Oligo-dT affinity purification using Dynabeads Oligo(dT)25 (Dynal, Oslo, Norway). cDNA was synthesized using a ProStar First Strand RT-PCR kit as described manufacturers protocol (Stratagene).
RAP PCR.
The differential display PCR reactions were performed with 1 µl of cDNA, 1x Goldstar reaction buffer, Seraing, Belgium) per 20 µl reaction. Cycles were performed as follows: 3 min 96°C, 2x (1 min 96°C, 5 min 37°C, 5 min 37°C to 72°C), 30x (1 min 96°C, 2 min 50°C, 5 min 72°C) and 10 min 72°C. The annealing temperature was increased stepwise from 37°C to 50°C allowing the arbitrary primer to bind over multiple homologous regions. From the PCR reaction, 5µl was mixed with 5µl of 96% formamide loading buffer (0.05% (wt/vol) xylene cyanol, 0.05% (wt/vol) bromophenol blue) and boiled for 2 min. The amplified cDNAs were loaded on a 6% sequencing gel and subjected to electrophoresis. Gels were vacuum dried and autoradiographed with Biomax MR film (Eastman Kodak, Rochester, NY) at -70°C. The dried gel and autoradiogram were orientated and cDNA bands of interest were excised and immersed in 100µl TE. DNA was eluted by twice freezing and thawing in liquid N 2 and vortexing. Samples were extracted twice with phenol-chloroform-isoamylalcohol (25:24:1) and once with chloroform-iso-amylalcohol. cDNA was re-amplified by using 5-10µl in a standard 50µl PCR reaction and utilizing the primer used for the original differential display (annealing temperature, 50°C). The mixture was separated by agarose gel electrophoresis, bands were excised, purified with Glassmax (Life Technologies Inc., Paisley, UK) and cloned in pGEM-T (Promega, Madison, WI) or PCR-script (Stratagene, La Jolla, CA). Plasmid DNA was isolated from 5 to 8 colonies per excised band and inserts sequenced.
Northern blotting analysis.
PMNs (97% neutrophils; <3% eosinophils) were isolated from blood obtained from healthy volunteers from the Red Cross Blood Bank, Utrecht, The Netherlands, as described above. Cells were incubated in the presence or absence of GM-CSF (10 -10 M) or TNFα (100 U/ml) in RPMI-medium (Life Technologies Inc., Paisley, UK) supplemented with 25mM Hepes, 8% fetal calf serum, 1mg/ml penicillin and 1mg/ml streptomycin in a CO 2 incubator (5% CO 2 , 37°C). Cells were washed twice with PBS and total RNA was isolated using the acid-phenol method 15 . 20µg RNA was lyophilized and separated on a 0.8% agarose formaldehyde gel. RNA was transferred to Hybond-N membranes (Amersham, Rainham, UK) by capillary transfer using 10x SSC (1.5M sodium chloride, 0.15M sodium citrate) overnight. The blots were washed and baked for 2 hours at 80°C. Differential display fragments were used as probes and were labeled with α[
32 P]-dCTP by Rediprime random priming according to manufacturer protocol (Amersham, Rainham, UK). Blots were hybridized overnight at 42°C, washed subsequently with 2x SSC/0.1% SDS, 1x SSC/0.1% SDS, 0.1x SSC/0.1% SDS, and exposed to film (Kodak, Rochester, NY). A 1.4kb cDNA fragment of the human glyceraldehyde-3-phosphate dehydrogenase gene was used to control for equal loading.
Allergen challenge.
Patients used for this study had a history of periodic wheeze and demonstrated a reversibility of more than 15% in forced expiratory volume in one second (FEV 1 ), 15 minutes after inhalation of 400µg salbutamol from a pressurized metered dose inhaler attached to an aerosol chamber (Volumatic®, Allen and Hanburys, Greenford, UK). None of them had used oral corticosteroids in maintenance dose during 12 months before the study. All subjects were clinically stable at the time of the study and had no evidence of systemic or respiratory disease. On the day of the experiment, the FEV 1 value was >60% predicted. Furthermore, patients were required to show an increased bronchial hyperresponsiveness to histamine with a provocative concentration causing a 20% fall in FEV 1 of less than 4.0mg.mL -1 (PC 20 <4.0mg.ml -1 ), and a fall in FEV 1 within 1 hour after allergen inhalation challenge of at least 20%.
All patients had blood eosinophilia (>5%) and raised levels of total serum IgE and specific IgE antibodies to either house dust mite or cat. Patient data is summarized in Table 1 . Bronchial provocation with allergen was performed by 2 min inhalations (tidal breathing) with 10 min intervals. Allergen provocation was preceded by an initial aerosol of buffer (2.5mg/ml NaHCO 3 with 5mg/ml NaCl, 0,03% HAS and 0.5% phenol) to which none of the patients reacted with a fall in FEV 1 . Increasing concentrations of antigen aerosol were delivered through a nebulizer (model 646, de Vilbiss Co, Somerset, PA). House dust mite antigen (10,000 biological units/ml; Allergy Laboratory Copenhagen, Denmark) and cat (10,000 biological units/ml; Allergy Laboratory Copenhagen, Denmark) were diluted from stock solution and the dilution used for the first inhalation was calculated from the skin-prick test and the pre-antigen PC 20 for histamine according to Cockcroft et al. 16 . Inhalations were performed by stepwise doubling the dose of antigen until the FEV 1 fell at least 20% from baseline values. Blood was collected at various time points after allergen challenge as indicated via an intravenous catheter and was anti-coagulated with 0.4% (wt/vol) trisodium citrate (pH 7.4) and kept at 4 °C. Total leukocytes were isolated after isotonic lysis of the erythrocytes in ice-cold ammonium chloride solution containing 155mM NH 4 Cl, 10mM KHCO 3 , 0.1mM EDTA (pH 7.2). Total RNA isolation, blotting and hybridization were performed as previously described. 
Results
Method of differential screening for cytokine induced genes
Little is currently known concerning the regulation of genes expressed in response to cytokine-challenge of human granulocytes. Genes that are regulated by cytokines may be utilized as potential markers for pre-activation or "priming" of these phagocytes. Furthermore, these genes may provide greater insight into the pathogenesis of inflammatory disorders. In order to identify differentially expressed genes several approaches have been previously been utilized. For example, subtractive hybridization or differential hybridization is an approach based on removing the common transcripts between different cell types or tissues, leaving the specific transcripts for further manipulation and analysis. These are mainly qualitative methods and extremely time consuming. Secondly, nuclear run-on transcription has been applied to analyze changes in the level of expression of mRNAs but this method can only be applied to the detection of changes in the expression of known genes.
More recently a novel method of analyzing gene expression, termed differential display, has been described 13 .
This technique provides a sensitive and flexible approach to the identification of genes that are differentially expressed at the mRNA level. Differential display is based up on selective reverse transcription of expressed mRNAs and subsequent amplification using PCR in which a radioactive label is included. For the PCR reaction an anchored oligo-dT primer is utilized to selectively amplify a subset of mRNAs. The amplified, labeled PCRfragments can then be separated and compared on a polyacrylamide gel with cell specific band patterns. A modification of this technique termed Random Arbitrary Primed (RAP)-PCR has been utilized in this study 14 , and the procedure is represented schematically in Figure 1 . In this modification, a single arbitrary primer is utilized in the PCR cycles. Such an arbitrary primer can be selected with the criteria that it should be approximately 18bp long and have roughly a 50% (A/T):(G/C) ratio and have an annealing temperature of around 50 O C (see Table 2 and Ref 14) .
Primers were also selected that generated between 20-50 bands per lane. This primer is allowed to anneal to the reverse-transcribed PMN cDNA at low temperature, allowing it to act as both a forward and reverse primer. It thus tends to select a subset of cDNAs with somewhat palindromic 5'-and 3'-sequences. A disadvantage of the original anchored oligo-dT method was the identification of many 3'-untranslated regions of genes, which are difficult to analyze. The RAP-PCR protocol does not restrict primer annealing to these untranslated regions and thus provides greater opportunities to amplify the coding regions of differentially expressed genes. This leads to a more rapid analysis of the identification of the cloned gene. Primers were tested for their suitability in this assay and were selected by two criteria, the length should be around 18 base pairs and the annealing temperature should be above 50°C. Arbitrary primers were subsequently chosen that met these criteria and are listed in Table 2 . Human PMNs are isolated from 500ml whole blood and cultured in the presence or absence of GM-CSF. Total RNA is isolated, poly-A+ mRNA and cDNA prepared and subjected to RAP-PCR analysis. Up-or down-regulated bands were excised, cloned and sequenced. See Materials and methods for full-details. 
Identification of novel GM-CSF induced genes in human PMNs
RAP-PCR was performed on RNA isolated from human granulocytes treated with or without GM-CSF (10 -10 M) for 3 hours, as described in the Materials and Methods. Samples were analyzed by acrylamide gel electrophoresis as shown in Figure 2 . Around 30 fragments were found to be clearly differentially regulated and most of them represented up-regulation in the presence of GM-CSF. Each differentially expressed band was excised from the gel and amplified with the original primer used for differential display reactions. The fragments obtained were cloned and partially sequenced. These sequences were then screened against available nucleotide databases and the results of the sequence comparisons are outlined in Tables 3 and 4 . These tyrosine-based motifs implicate ILT-2 in inhibitory signaling pathways. Furthermore, the transcription factor c-fos was identified. c-Fos is transiently induced by a wide variety of extracellular stimuli 19 . Ferritin, another gene identified, is the major iron-storage protein in eukaryotes, also has a potential role in the regulation of myelopoiesis and furthermore, has been implicated as a tumor marker 20 .
Although we found several previously described genes many novel sequences were also identified that, at this time, have no identity to either known genes or human Expressed Sequence Tags (EST) sequences (Table 4 ). The percentage homology of these clones with EST clones is given along with the length of the insert obtained after cloning the RAP-PCR product. Extensive work is now required to determine the identity of these coding sequences and to correlate their expression with cytokine priming. Table 3 ). 
Confirmation of GM-CSF-mediated induction of genes in human PMNs
To confirm that the genes isolated were indeed differentially expressed, Northern blots of total RNA from human PMNs (97% neutrophils; <3% eosinophils) incubated with GM-CSF were probed with selected cDNAs. Figure 3a shows a strong up-regulation of the FLAP gene after 3 hours treatment with GM-CSF. Similarly, ILT-2 mRNA was also rapidly induced after 3 hours. Since c-fos mRNA is known to be very rapidly induced by extracellular stimuli 21 , we prepared a northern blot including a 30 minutes GM-CSF time point. Indeed, c-fos expression was extremely rapidly and transiently up regulated, being optimally expressed after 30 min. Interestingly while c-fos appears to be both rapidly and transiently up-regulated, as is characteristic of immediate early genes, both FLAP and ILT-2 are slower, and levels remain high for at least 3 hours. Data was confirmed in at least three independent donors. These data demonstrate that the genes identified as being differentially expressed by the RAP-PCR technique are indeed upregulated in human PMNs stimulated with GM-CSF. 
FLAP is rapidly induced in human PMNs by both GM-CSF and TNFα
To analyze the duration and extent of FLAP expression in human PMNs in detail, we prepared RNA from cells stimulated for up to 6 hours with GM-CSF. Interestingly, while FLAP expression is rapidly induced, it remains high for at least 6 hours (Fig. 4A ). Since the "lifespan" of human neutrophils is rather short, even in the presence of cytokines, it appears that once FLAP is upregulated, it remains highly expressed until the granulocyte apoptotic program is induced. Thus, FLAP provides a somewhat permanent marker for the activation status of these phagocytes. To determine if FLAP may be induced by other inflammatory stimuli and thus a general marker of inflammation, we also stimulated human PMNs with TNF-α. Again, the expression of FLAP in PMNs treated with TNF-α was increased and remained high for at least 6 hours (Fig. 4B ). This suggests that at least some of the GM-CSF-stimulated mRNAs are also markers of a common pool of inflammatory cytokine-induced genes. 
Allergen challenge induces FLAP-expression in peripheral blood leukocytes in vivo
We wished to determine whether the increase in FLAP-expression we observed by in vitro stimulation of PMNs could also be observed in vivo. To do this, we analyzed FLAP-expression in the total leukocyte population from allergic asthma patients after allergen inhalation challenge. Total leukocytes were utilised and not PMNs for several reasons: (1) it is not possible to isolate sufficient amounts of eosinophils and neutrophils from 10ml of blood to obtain enough mRNA for northern blotting. (2) Isolation of cells takes at least 2 hrs (neutrophils) or 4 hrs (eosinophils). These rather long isolation times can interfere with the detection of fast and transient-induced genes. (3) By using total leukocytes, aspecific priming caused by the isolation procedures was minimized. Blood was collected after allergen challenge and leukocytes isolated as indicated in detail in the Materials and Methods. Northern blots of RNA from two patients who were allergic to either house-dust mite or cat were probed for FLAP mRNA expression. The methodology used for allergen challenge is detailed in the Materials and Methods. The expression of FLAP in vivo was also very rapidly induced, reaching a maximum level in both patients between 30 min and 1 hour, before decreasing to basal levels within 4-5 hours ( Figure 5 ). This decrease to basal levels is in contrast to what was observed in isolated PMNs stimulated in vitro with cytokines (see Figure 4 ). This discrepancy is likely to reflect the fact that in these in vivo experiments the primed leukocytes will migrate out of the peripheral blood after several hours. These data demonstrate that gene expression identified in vitro by cytokine challenge of human PMNs reflects the in vivo situation after induction of an inflammatory response. 
Figure 5: FLAP expression is increased in leukocytes isolated from allergic asthmatics after allergen inhalation challenge.
Total RNA was prepared from total white cell fractions of blood taken from patients before (control) and after allergen challenge at the times indicated. (A) House-dust mite allergen (10.000 biological units/ml) and (B) Cat allergen (10.000 biological units/ml) were utilized. Inhalations were performed as previously described and samples were collected after the FEV 1 was at least 20% below baseline values. 10µg of total RNA per lane was loaded and blots were probed with the differential display fragment of FLAP (upper panels). Blots were subsequently re-probed with GAPDH to correct for equal loading (lower panels). 
Discussion
Phagocytes (granulocytes and monocytes) in the peripheral blood are characterized by a non-primed phenotype that is refractory to activation in the context of cytotoxic responses [2] [3] [4] . This is a safeguard for the inappropriate activation of these cells in the peripheral blood. In severe clinical conditions, such as septic shock, uncontrolled activation of phagocytes can lead to multi organ failure and death. At inflammatory loci, such as bronchial tissue in allergic asthma, eosinophils are attracted to the site of inflammation and become activated 1 . The process of extravasation of inflammatory cells to these loci is a tightly controlled multistep process. The first step involves the interaction of phagocytes in the peripheral blood by cytokines liberated from the inflammatory locus. This results in pre-activation or priming of cells, which is essential for their subsequent extravasation and the eventual activation of cytotoxic responses upon interaction with activating stimuli. Therefore, the process of priming is critical for regulation of phagocyte effector functions in vivo. This multistep paradigm of phagocyte activation predicts that cytokinemediated priming of peripheral blood granulocytes is a result of a local inflammatory reaction in a given organ. Indeed, several studies have shown that inflammatory cells are characterized by a primed phenotype in the peripheral blood of patients with allergic inflammatory conditions [22] [23] [24] [25] . Understanding the mechanisms of priming might be useful in the development specific approaches to inhibit this phenomenon thereby preventing inflammatory cells becoming optimally activated. Moreover, this in vivo primed phenotype of inflammatory cells in the peripheral blood might be used to develop strategies to measure this phenotype as read out for the severity of inflammatory processes localized in tissues. This diagnostic approach has been followed by Venge and colleagues who have measured the release of eosinophil cationic protein by eosinophils in the blood of allergic asthmatics ex-vivo 26;27 . This phenomenon occurs during clotting of blood in samples of patients with various inflammatory diseases in particular allergic asthma 28 . The ability of eosinophils to release ECP under these conditions can be considered as an indirect measure of eosinophil priming in vivo. We have tried to measure priming of isolated eosinophils as a measure of changes in inflammatory processes in the lung during anti-inflammatory treatment (unpublished data.). Although PAF-induced eosinophil chemotaxis is inhibited by this type of treatment, functional eosinophil responses such as chemotaxis and activation of the respiratory burst cannot be routinely used for this type of study. The methodology is too laborious and the data are too sensitive for variations in processing of the cells. Despite recognition of the importance of priming, very little is currently known as to the precise molecular mechanisms of this phenomenon. Therefore, we set out experiments to find new determinants of cytokine-induced priming utilizing the technique of differential display. This powerful PCR based technique has enabled us to define several mRNAs that were either up-or down regulated during GM-CSF treatment of PMNs in vitro (see Table 3 ). While utilizing RAP-PCR will not lead to the identification of all genes regulated by cytokine priming it does result in the identification of a large subset of genes. In this article alone we describe around 25 unknown genes that must now be subsequently characterized (Table 4) . Interestingly, two of the genes identified, ferritin-H and cytochrome oxidase, were also identified as allergen induced genes in monocytes isolated from mononuclear cells of patients with allergic asthma 29 . Ferritin-H plays an important role in iron storage and iron sequestration 20 . Our data suggest that in human PMNs, GM-CSF may play a role in regulating iron homeostasis through regulating the expression of ferritin-H. Indeed it has been reported, in primary human myoblasts, that TNFα induces ferritin-H mRNA independently of cellular iron concentrations and known iron-dependent regulatory pathways 30 . This suggests that regulation of iron homeostasis by inflammatory cytokines might be a general response of cells. Increased sequestration of iron by increasing the levels of ferritin-H might serve the beneficial functions of, (a) making iron unavailable to invading organisms or, (b) reducing free-radical tissue damage. The latter may play an important role in phagocyte functioning, protecting cells against damage during the killing of microbial organisms by superoxide production.
We have also identified the transcription factor c-fos as a rapidly upregulated gene in PMNs (Fig. 3c ). This transcription factor is a member of a family of immediate early response genes whose expression is regulated by a variety of cytokines, growth factors and hormones 19 . Once expressed, it is then able to bind and activate the promoters of a diverse array of cellular genes. Thus, GM-CSF induced c-fos expression in human neutrophils may be responsible for rapidly "switching on" relevant target genes needed for initiating a correct inflammatory response.
Another GM-CSF regulated gene identified is the immunoglobulin-like transcript 2 (ILT-2; Fig. 3b ), a transmembrane protein that is expressed on many myeloid and lymphoid cells 18 . This receptor binds MHC class I molecules and delivers a negative signal that inhibits killing by NK and Tcells, as well as Ca 2+ -mobilization in B cells triggered through the B-cell antigen receptor 31 . Cytokine regulated expression of this gene has not previously reported neither has its expression in neutrophils. Our finding that ILT-2 can be upregulated by GM-CSF suggest a potentially novel mechanism for regulating cellular activation during an immune response. 5-lipoxygenase activating protein (FLAP) was identified as a gene potently upregulated in neutrophils treated with GM-CSF and TNFα (Fig. 4) . This protein is a critical component in the synthesis of leukotrienes 17 . Leukotrienes are secreted by neutrophils, eosinophils, mast cells and macrophages and potently stimulate bronchoconstriction and mucous secretion, and cause vasodilatation with increases in postcapillary permeability 32 . It is thus interesting that through differential display we were able to identify FLAP as a marker of primed granulocytes in vitro. The consequences of FLAP upregulation are thus likely to be an increased inflammatory response. Differential display was utilized to find determinants of priming in the peripheral blood of allergic asthmatics. The most prominent signal in vitro was found with the FLAP mRNA on Northern blots from cytokine treated granulocytes. To confirm that genes identified in vitro were also relevant in vivo, mRNA was prepared from total leukocytes isolated from allergic asthmatic patients before and after allergen challenge. Total leukocytes were chosen over isolated PMNs, due to the relatively long time of isolation and the sensitivity of these granulocytes for aspecific pre-activation during isolation 33 . As can be seen from Figure 5 , FLAP mRNA is rapidly induced after allergen challenge and this increase is transient. These findings are consistent with a model that inflammatory blood cells encounter priming signals in the peripheral blood. These cytokines modulate the transcription of several genes including the induction of the FLAP gene. Moreover, these cells become much more responsive to chemotactic factors 34 . These primed cells are destined to leave the bloodstream and extravasate into the tissues leaving the unprimed cells in the peripheral blood. The observation that FLAP is also upregulated in vivo validates our chosen methodology. Further in vivo analysis of both the known and unknown genes identified in our screen may well lead to the identification of novel markers of inflammation as well as further insight into immune regulation. Concluding, differential display enables the characterization of genes that are differentially transcribed in response to cytokines and are relevant for the pathogenesis of inflammatory diseases. This occurs in vitro and in vivo in patients with symptomatic asthma. Characterization of novel genes will enable us to find new markers of inflammatory diseases and will provide valuable information on the processes that occur early in the sequence eventually leading to activation of inflammatory cells in the tissues.
